Clinical Trial Update: ACP-204 in Adults With Alzheimer's Disease Psychosis [Phase 2, Phase 3]

View source ↗

Summary

ACADIA Pharmaceuticals is evaluating ACP-204 in Phase 2 and Phase 3 trials for Alzheimer's disease psychosis, and the studies are currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ACP-204

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Alzheimer's Disease Psychosis | Phase 2, Phase 3 | Status: RECRUITING